Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Search results for "Phase 3 clinical trial"
Home
Chong Kun Dang’s CKD-339 Enters Phase 3 in South Korea for Patients Uncontrolled on Monotherapy
CKD-339, an essential hypertension treatment under development by Chong Kun Dang, is advancing into a Phase 3 clinical trial in South Korea.
07/31/2026, 20:45 ET
Placebo Outperforms TG-C: Data Errors and Stock Volatility Cloud Kolon TissueGene’s Phase 3 Trial
Kolon TissueGene’s knee osteoarthritis cell and gene therapy, TG-C, has failed to achieve statistical significance on its primary endpoints in its...
07/27/2026, 08:06 ET
Fast-Tracking Biosimilars: South Korea to Waive Phase 3 Clinical Trials Under New Guidelines
South Korean regulators have revised requirements to significantly reduce the time and financial burden of biosimilar...
07/16/2026, 04:06 ET
MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem
South Korean biotechnology company MediPost has entered full-scale Phase 3 clinical testing in the United States for...
07/12/2026, 01:39 ET
GC Biopharma to Conduct Phase 3 Clinical Trial for Two-Dose Chickenpox Vaccine in South Korea
GC Biopharma’s chickenpox vaccine, Barycela Inj., is set to enter a Phase 3 clinical trial in South Korea to confirm...
07/06/2026, 03:44 ET
GC Wellbeing’s Laennec Injection Clears Phase 3 Hurdle for IV Drip Use, Boosting Growth Prospects
GC Wellbeing announced on June 16 that it has secured topline results demonstrating that its chronic liver disease...
06/17/2026, 22:48 ET
HK inno.N’s Obesity Drug Candidate Outperforms Wegovy in Head-to-Head Phase 2 Trial
HK inno.N announced on June 9 that its obesity drug candidate, ecnoglutide, demonstrated superior weight-loss efficacy...
06/11/2026, 07:43 ET
Combination Therapy: Laennec Achieves Pain Relief with One-Fifth the Steroid Dose in Preclinical Study
An animal study has revealed that combining GC Green Cross Wellbeing’s human placental hydrolysate treatment, Laennec...
08/21/2026, 21:10 ET
Moderna’s Landmark mRNA Cancer Vaccine Phase 3 Success Spotlights Korean Biotech Ties
Positive late-stage clinical results for a personalized messenger RNA cancer vaccine developed by Moderna and Merck are...
08/21/2026, 04:14 ET
Zinc and Selenium Deficiencies Linked to Heightened Inflammation in Critically Ill Patients
For families with loved ones in an intensive care unit , lab reports often feature unfamiliar line items alongside...
08/20/2026, 01:51 ET
1
2
3
Next
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية